20th Dec 2007 16:04
Dechra Pharmaceuticals PLC20 December 2007 Dechra Pharmaceuticals PLC (the Company) Directors / PDMR Sharedealing 20 December 2007 Dechra Pharmaceuticals PLC announces that, on 19 December 2007, the followingDirectors and PDMR's exercised options over ordinary shares of 1p each in theCompany, granted to them on 16 November 2004 pursuant to the DechraPharmaceuticals Plc Long Term Incentive Plan (the LTIP), at an exercise price of£1 each: Name Capacity Options Shares Sale Total beneficial shareholding Exercised Sold Price following this announcement per share Ian Director 48,589 48,589 £3.50 662,819Page Simon Director 33,096 0 0 789,868Evans Edwin Director 31,348 31,348 £3.50 393,990Torr Giles PDMR 17,768 7,308 £3.50 44,898Coley Mike PDMR 28,213 11,603 £3.50 642,382Annice Peter PDMR 23,511 9,670 £3.50 43,280Graham The exercise of the LTIP options were subject to the achievement of performanceconditions which were satisfied in full. All Directors (other than Simon Evans) and PDMR's have sold 41% of theshareholding acquired pursuant to the LTIP exercise in order to fund theresulting tax liability. Ian Page and Ed Torr have both sold the remaining 59%of the shareholding acquired with the intention of taking up additionalentitlements in respect of the Company's Placing and Open Offer (announced on 12December 2007) over and above their proposed investments stated in theProspectus. As a result of this additional investment Ian Page will now seek to invest atotal of £164,825 in the open offer and Ed Torr a total of £99,402. Enquiries: Zoe Bamford Company Secretary 01782 771100 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
DPH.L